Pharmacological management of pain, anxiety, and depression in general practice. Mental and Behavioural Disorders
Conditions
Interventions
This is a convergent mixed-methods approach. The quantitative component will allow for the measurement of potential prescription differentials using patient data from the ESND (National Health Data Sy
Sponsors
Inserm
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Quantitative component: The study will include all individuals aged 18 and over in France, using data from the National Health Data System (SNDS). Qualitative component: The qualitative analysis will involve general practitioners practicing in private offices or community health centers. It will focus on consultations with patients who either present with complaints of pain, anxiety, or depression, or in which such issues arise during the consultation.
Exclusion criteria
Exclusion criteria: Persons under 18 or unable to give consent (for qualitative approach).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The association between the reimbursement of analgesic, anxiolytic, and/or antidepressant medications and the sex of the patient, the sex of the physician, and their interaction, measured using collected and linked patient and physician data, at one timepoint 2. Gender-related prescription differentials measured using qualitative data collected during GP consultations, at one timepoint | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The association between the reimbursement of daily sick leave benefits among patients who have been prescribed analgesics and/or psychotropic medications, and the sex of the patient, the sex of the physician, and their interaction, measured using collected and linked patient and physician data, at one timepoint 2. Patients' expressions of pain, anxiety, and/or depression that may contribute to gender-based differences in prescribing practices, measured using data collected during GP consultations, at one timepoint 3. Patients’ complaints interpreted, discussed, and received by GPs, measured using data collected during GP consultations, at one timepoint 4. Medication prescribing carried out during the consultation—focusing on how treatment is presented, discussed, negotiated, and the extent to which shared decision-making is involved - using data collected during GP consultations, at one timepoint 5. Patients’ experiences of the consultation about their presenting complaint and the resulting prescription measured using data collected during GP consultations, at one timepoint | — |
Countries
France
Contacts
Public ContactNathalie Pelletier-Fleury
Outcome results
None listed